Shun Fang

995 total citations
22 papers, 781 citations indexed

About

Shun Fang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shun Fang has authored 22 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Shun Fang's work include Lung Cancer Research Studies (7 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). Shun Fang is often cited by papers focused on Lung Cancer Research Studies (7 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). Shun Fang collaborates with scholars based in China and United States. Shun Fang's co-authors include Linlang Guo, Yuchun Niu, Man Li, Ting Wei, Weimei Huang, Feng Ma, Ruixiang Tang, Jie Yang, Hong-Yi Gao and Man Li and has published in prestigious journals such as Diabetes, British Journal of Cancer and Molecular Cancer.

In The Last Decade

Shun Fang

22 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shun Fang China 13 648 492 113 57 35 22 781
Guoxing Feng China 15 570 0.9× 323 0.7× 75 0.7× 48 0.8× 45 1.3× 24 711
Kristin Wächter Germany 8 894 1.4× 422 0.9× 60 0.5× 30 0.5× 24 0.7× 16 1.0k
Kai Fang China 14 572 0.9× 428 0.9× 102 0.9× 36 0.6× 91 2.6× 40 728
Ting Sun China 12 428 0.7× 225 0.5× 138 1.2× 62 1.1× 44 1.3× 19 611
Xiaolan Chang China 15 316 0.5× 171 0.3× 62 0.5× 49 0.9× 43 1.2× 23 522
Song-Mei Liu China 12 604 0.9× 359 0.7× 44 0.4× 40 0.7× 21 0.6× 17 703
Zhicheng Pan China 16 669 1.0× 143 0.3× 44 0.4× 51 0.9× 43 1.2× 23 858

Countries citing papers authored by Shun Fang

Since Specialization
Citations

This map shows the geographic impact of Shun Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shun Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shun Fang more than expected).

Fields of papers citing papers by Shun Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shun Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shun Fang. The network helps show where Shun Fang may publish in the future.

Co-authorship network of co-authors of Shun Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Shun Fang. A scholar is included among the top collaborators of Shun Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shun Fang. Shun Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Huimin, Yu Song, Man‐Man Yu, et al.. (2023). Aspartic acid/arginine enhance the stability of gelatin emulsions. Journal of Food Engineering. 361. 111735–111735. 10 indexed citations
2.
Wang, Shuyu, Fanrui Zeng, Shu‐Mei Liang, et al.. (2022). lncRNA Linc00173 modulates glucose metabolism and multidrug chemoresistance in SCLC: Potential molecular panel for targeted therapy. Molecular Therapy. 30(4). 1787–1787. 5 indexed citations
3.
Zhao, Xiaoli, Ling Chen, Qingyun Ren, et al.. (2021). Potential Applications in Sewage Bioremediation of the Highly Efficient Pyridine-Transforming Paenochrobactrum sp.. Applied Biochemistry and Microbiology. 57(3). 344–350. 2 indexed citations
4.
Peng, Fenfen, Wangqiu Gong, Shuting Li, et al.. (2020). circRNA_010383 Acts as a Sponge for miR-135a, and Its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy. Diabetes. 70(2). 603–615. 97 indexed citations
5.
Li, Deyu, Meng Zheng, Bin Chen, et al.. (2020). FGFRL1 affects chemoresistance of small‐cell lung cancer by modulating the PI3K/Akt pathway via ENO1. Journal of Cellular and Molecular Medicine. 24(3). 2123–2134. 31 indexed citations
6.
Peng, Fenfen, Wangqiu Gong, Shu‐Ting Li, et al.. (2020). circRNA_010383 Acts as a Sponge for miR-135a and its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy. Diabetes. 70(2). db200203–db200203. 85 indexed citations
7.
Zhu, Tao, et al.. (2019). Primary pulmonary lymphoepithelioma-like carcinoma combined with situs inversus totalis. Chinese Medical Journal. 132(2). 223–226. 1 indexed citations
8.
Li, Man, et al.. (2019). Integrated high-throughput analysis identifies super enhancers associated with chemoresistance in SCLC. BMC Medical Genomics. 12(1). 67–67. 18 indexed citations
9.
Chen, Rui, Bin Chen, Deyu Li, et al.. (2019). HOTAIR contributes to chemoresistance by activating NF-κB signaling in small-cell lung cancer.. PubMed. 12(8). 2997–3004. 8 indexed citations
10.
Fang, Shun, Bin Chen, Longfei Jia, et al.. (2018). H3K27me3 induces multidrug resistance in small cell lung cancer by affecting HOXA1 DNA methylation via regulation of the lncRNA HOTAIR. Annals of Translational Medicine. 6(22). 440–440. 48 indexed citations
12.
Niu, Yuchun, Feng Ma, Weimei Huang, et al.. (2017). Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Molecular Cancer. 16(1). 5–5. 194 indexed citations
13.
Gao, Hong-Yi, Yuchun Niu, Man Li, Shun Fang, & Linlang Guo. (2017). Identification of DJ‐1 as a contributor to multidrug resistance in human small‐cell lung cancer using proteomic analysis. International Journal of Experimental Pathology. 98(2). 67–74. 20 indexed citations
14.
Chen, Zhenzhu, Hong-Yi Gao, Man Li, et al.. (2017). Targeted radionuclide therapy for lung cancer with iodine-131-labeled peptide in a nude-mouse model. Anti-Cancer Drugs. 28(5). 480–488. 3 indexed citations
15.
Wei, Ting, Weiliang Zhu, Shun Fang, et al.. (2017). miR-495 promotes the chemoresistance of SCLC through the epithelial-mesenchymal transition via Etk/BMX.. PubMed. 7(3). 628–646. 22 indexed citations
16.
Tang, Ruixiang, Yingying Lei, Jie Yang, et al.. (2016). WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway. British Journal of Cancer. 115(2). 243–251. 34 indexed citations
17.
Zou, Zhaowei, et al.. (2016). Gap junction composed of connexin43 modulates 5-fluorouracil, oxaliplatin and irinotecan resistance on colorectal cancers. Molecular Medicine Reports. 14(5). 4893–4900. 10 indexed citations
18.
Fang, Shun, Hong-Yi Gao, Yue Tong, et al.. (2015). Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells. Laboratory Investigation. 96(1). 60–68. 97 indexed citations
19.
Fang, Shun, et al.. (2014). Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer. Experimental and Molecular Pathology. 96(3). 438–444. 39 indexed citations
20.
Jiang, Yanyi, et al.. (2009). Nd:YAG lasers at 1064 nm with 1-Hz linewidth. Applied Physics B. 98(1). 61–67. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026